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A sequence with a specific residue at each position was proposed for the y
chain of human fetal hemoglobin by Schroeder et al.1 after a study in which
hemoglobin from a number of individual infants was used. We have now ex-
amined in part the fetal hemoglobin components of 17 additional infants and
have observed that position 136 of the y chain may be occupied not only by a
glycyl residue, as previously reported, but also by an alanyl residue.
Experimental.-Source of hemoglobin: Samples were taken from the umbilical cord or
by venipuncture. Four specimens contained an abnormal hemoglobin F (or a2,y2x) and
one an elevated percentage of hemoglobin Bart's or 74 (Table 1).
Nomenclature: The dual system of nomenclature for hemoglobin components as used
in this paper distinguishes between the methods of isolation to be described below. F1,
F,,, etc., apply to hemoglobins isolated by IRC-50 chromatography, and F1, Fo, etc.,
to those isolated by O-(diethylaminoethyl)-Sephadex (DEAE-Sephadex) chromatog-
raphy. They may be equated as follows: F,, = Fo, major fetal hemoglobn; F, = F1,
minor fetal hemoglobin; All = Ao, major adult hemolgobin; A2, the minor adult com-
ponent a262; and F-, an abnormal fetal hemoglobin a2'y2.
Isolation of hemoglobin: Solutions of hemoglobin were prepared from the cells as de-
scribed by Clegg and Schroeder.2 In a few instances, cord hemoglobin was used without
separation of the fetal and adult hemoglobins. Individual hemoglobins were isolated by
chromatography on Amberlite IRC-50 (ref. 1) or on DEAE-Sephadex.' Hemoglobins F.
from subjects D. P., W. B., C. W., and J. B. are aberrant in the My chain. F. from D. P.
has an electrophoretic mobility similar to hemoglobin FTexa, (ref. 4), those from W. B.
and C. W. much like hemoglobin F~arren (ref. 5), and that of J. B. near to hemoglobin
Bart's or Y4; further characterization will be published elsewhere. Heme was removed
from all preparations as previously described,' but the globin was dried and not dialyzed.
Some samples were aminoethylated.6 y Chains were prepared by chromatography.7
Reaction with cyanogen bromide: The sample was dissolved in 70% formic acid at a
concentration of 5 mg/ml, and cyanogen bromide (Matheson, Coleman, and Bell, or
Eastman) equivalent to 30 times the methionine content was added. After 16 hr at room
temperature in the dark, the reaction mixture was diluted with 10 times its volume of
water and lyophilized.
Isolation of peptides: Initial separation of peptides was made by passage through Bio-
TABLE 1. Data for subjects with abnormal fetal hemoglobins.
Fx/(Fo +
Percentages of Hemoglobin Components-- F, + F.)
Subject Race Sex F, F, F, Y4 Ao A2 X 100
D.P. Cauc. M 68.2 7.5 10.5 ... 13.8 <0.1 12.2
W. B. Negro M 64.6 9.6 11.6 .. 14.1 0.1 13.5
C. W. Negro M 59.9 10.3 10.3 ... 19.4 0.15 12.8
J. B. Negro-Cauc. F 60.3 9.4 8.9 ... 21.3 0.1 11.5
W. S. Negro M 68.8 7.9 0 6.9 16.3 <0.1
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Gel P-100 (Bio-Rad Laboratories, Richmond, Calif.). During the equilibration of Bio-Gel
P-100 in 50% acetic acid, a small amount of fine material was removed. Columns were
then poured in tubes that had been treated with Desicote (Beckman Instruments, Inc.,
Fullerton, Calif.). For most separations, two columns in series were used: effluent from
the first was passed through small-bore polyethylene tubing into the second at a point
several millimeters below the upper surface of the Bio-Gel. Each column of the series
was 1 X 160 cm when the sample was 50-100 mg and 2.2 X 160 cm when it was 20'0-300
mg. The sample was placed on the column in 50% acetic acid, which was also used as
developer at a flow rate of 6 ml per square centimeter of cross-sectional area per hour.
All separations were made at room temperature.
The desired peptide was purified by chromatography on a 0.6 X 60-cm or a 1 X 100-cm
column of Dowex-1 (ref. 8). In later experiments, this system was modified to use 10 ml
of pH 9.4 buffer, 30 ml of pH 9.0 buffer, 40 ml of pH 8.4 buffer, 60 ml of pH 6.5 buffer,
and 100 ml each of 0.5 N and 2 N acetic acid for the smaller column. For special examina-
tion, the peptide was also chromatographed on a 0.6 X 60-cm column of Dowex-50-X8
(equivalent to fraction C of Moore et al.9). The gradient system was like that of Schroeder
et al. ° except that 83 ml of 0.1 M buffer at pH 3.1 and 166 ml ofM buffer at pH 5.0 were
used. The flow rate of developer was 10 ml per hour.
Amino acid analyses: The hydrolytic procedure has been described.' The analyses
were made on spherical resin in a model 120 amino acid analyzer (Beckman Instruments,
Inc., Palo Alto, Calif.), according to Benson and Patterson," with high-sensitivity cu-
vettes."2
Results.-Human hemoglobin F has methionyl residues at positions 32 and 76
of the a chain and at positions 55 and 133 of the y chain. If we label the pro-
spective peptides from cyanogen bromide cleavage" analogously to tryptic pep-
tides,'4 the number of residues in the several peptides is as follows: aCB-1,
32; ciCB-2, 44; aCB-3, 65; yCB-1, 55; yCB-2, 78; and yCB-3, 13. The sep-
aration of peptides from the cyanogen bromide cleavage of globin F is depicted
in Figure la. The identity of the peptides in the various zones is given.
The primary concern of this investigation was peptide 'yCB-3. The sequence
of the portion of the y chain that comprises this peptide is Val-Thr-Gly-Val-Ala-
Ser-Ala-Leu-Ser-Ser-Arg-Tyr-His.1 When peptide yCB-3 was isolated from
globin FII of subject J. H. (Table 2), the amino acid composition in terms of
residues was His, 0.97; Arg, 0.98; Thr, 0.90; Ser, 2.70; Gly, 0.71; Ala, 2.31;
Val, 2.00; Leu, 0.99; and Tyr, 0.88. If we take into account the usual hydro-
lytic destruction of threonine, serine, and tyrosine, only glycine and alanine do not
give essentially integral values. These results suggest that two peptides are
present and that they are identical in sequence except for glycine or alanine in the
third position. When the peptide was degraded for ten steps by the phenylthio-
hydantoin (PTH) method on paper strips,' the expected results were found ex-
cept in the third position where, indeed, both glycine and alanine were detected
(Fig. 2). On the other hand, alanine alone and no glycine was detected in the
fifth and seventh positions. Further evidence of two peptides was obtained
when the zone was pooled in several portions and each was analyzed; the
analyses showed an increasing ratio of glycine to alanine from the front to the
tail of the zone.
Data for additional samples are summarized in Table 2.
Discussion.-Except for nos. 18, 19, 21, and 23, which are the abnormal fetal
hemoglobins, all samples in Table 2 show more than one half and less than one
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residue of glycine in peptide 'yCB-3
and, therefore, force the conclusion
that a mixture of peptides is nor-
mally present. Consequently, he-
moglobin F,1(= Fo) as isolated must
have contained at least two types
of -y chains, which will be desig-
nated as 7136Gly and 7136Ala chains
in the subsequent discussion. When
the context requires, the position at
which the chains differ will also be
referred to synonymously as "resi-
due 3 of the yCB-3 peptide" or "resi-
due 136."
It is pertinent to ask, "If almost
all samples have a mixture of y136Gly
and 7136Ala chains, why was the se-
quence originally reported as y136Gly
only'?." In the original investiga-
tion, the data were derived from
tryptic peptide yT-15, which in-
cludes residues 133-144. To answer
the above question, yT-15 was iso-
lated from globin FI, of J. H. (sub-
ject 1, Table 2) by chromatography
on Dowex 50-X2 and Dowex-1-X2
as was originally done. Just as the








FIG. L.-(a) Peptides from cyanogen bromide
treatment of 220 mg of globin Fo from D. P.
Four 2.2 X 160-cm columns of Bio-Gel P-100
in series were developed with 50% acetic acid.
(b) Peptides from cyanogen bromide treatment
of 50 mg of aminoethylated globin Fo from D.
P. Two 1 X 160-cm columns of Bio-Gel P-100
in series were developed with 50% acetic acid.
partially separated on Dowex-50-X8 and
Dowex-1, so the mixed peptides of yT-15 separate partially on Dowex-50-X2.
Depending upon the way in which the fractions were pooled, most of the ala-
nine-containing yT-15 could be excluded in the initial isolation. We believe that
the fortuitous pooling of fractions eliminated the alanine-containing 'yT-15 in
our original investigation. It is not probable that the present results are dis-
torted in this way. In the first place, Bio-Gel chromatography is unlikely to
bring about even a partial separation; and secondly, care was taken to exclude
no portion of the zone either at this point or on purification by Dowex-1. This
point will be further discussed in another context below.
The data of Table 2 resemble results that have been reported by Bargetzi
et al." and Walsh et al.'6 for bovine carboxypeptidase A, by von Ehrenstein"
for the a chain of rabbit hemoglobin, by Rifkin et al.'8 and Popp"9 for the a
chain of several strains of mouse hemoglobin, by Kilmartin and Clegg'0 for the
a chain of horse hemoglobin, and by Huisman et al." for the a chain of goat
hemoglobin. In general, the data have been explained by assuming either a
genetic cause or an ambiguous translation of genetic material. Walsh et al. 16 con-
cluded that two allelomorphs occurred in the general bovine population, and
Huisman et al.2' presented strong evidence that nonallelic genes were respon-
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Val Val sible, but no conclusion could be reached in the
Ala ~~~~~Alaother cases.Ala
= ^1The hemoglobins Fz of D. P., W. B., C. W., and
Gly Gly J. B. (nos. 18, 19, 21, and 23, Table 2) have eitherglycine or alanine alone in position 136 of the y
Thr Thr chain. The results of PTH-degradations at resi-
due 3 of yCB-3 from various sources (Fig. 2) show
that FX of D. P. has only alanine and no trace of
glycine, whereas Fx of W. B. has only glycine
and no trace of alanine. The small amount of
glycine reported for D. P.'s F. (no. 18, Table 2)
is therefore probably due to impurities. Although
FIG. 2.-Results of PTH-deg- , .,
radations at residue 3 of several J. B.'s Fz, like D. P.'s, is believed to have only
yCB-3 peptides. Standards are alanine at residue 136, the data are less definitive
at left and right. Samples from because J. B.'s Fa, which emerges last from the
left to right derive from W. B.-F. DEAE-Sephadex column, contained some Fo and(no. 19), D. P.-Fo (no. 16), J.
H.-Fo (no. 1), J. L.-Fo (per- F1.
sistent high fetal hemoglobin These results from the hemoglobins Fx are in-
carrier), and D. P.-F2 (no. 18). terpreted to mean that the observed effects i
normal infants come from a genetic factor and not
from ambiguous translation. If ambiguous translation is involved, the different
Fr's should each show ambiguity at residue 136. If, on the other hand, multiple
structural genes are involved, some Fr's should have glycine in residue 136 and
some should have alanine. The latter state is observed: the mutated genes
which produce the Fx's yield distinct products that are related either to ,Y136G1y
or to y136Ala chains. Consequently, on the basis of this evidence, it may be con-
cluded that the two types of y chains in normal samples of hemoglobin F,, ( = Fo)
(as represented by nos. 1-12 in Table 2) stem from a genetic factor and not from
ambiguous translation.
TABLE 2. Analytical data on the yCB-3 peptide from several sources.
,-Residues--- --Residues---
Subject Glycine Alanine Material Subject Glycine Alanine Material
1. J. H. 0.71 2.31 Globin Fii 13. 0.72 2.43 Globin Fo
2. P. L. 0.77 2.23 Globin Fii 14. KW. S. 0.83 2.33 Globin F,
3. B. F. 0.88 2.14 Globin Fii 15.J 0.65 2.41 Globin 74
4. N.N. 0.68 2.35 GlobinFII 16.' 0.97 2.18)
5. B. G. 0.74 2.30 GlobinFII 0.87t 2.19 Globin Fot
6. J. M. 0.85 2.19 Globin Fii ED. P. 0.87 2.22J
7. C.O.* 0.76 2.28 -yChain 17. 0.87 2.22 GlobinF,
8. C. C.* 0.73 2.32 y Chain 18.J 0.16t 2.97 Globin Fx
9. G. W. 0.77 2.26 Cord globin 19. W. B. 1.04t 2.01 Globin Fx
10. B. W. 0.81 2.26 Cord globin 20. C W 0.83 2.21 Globin Fo11. B. K. 0.71 2.29 Cord globin 21.f 1.014 2.03 Globin F2
12. G. S. 0.79 2.31 Cord globin 22.J. B. 0.83 2.23 Globin Fo23.J B. 0.38t 2.73 Globin F,
* Samples 7 and 8 are mixtures of blood from two individuals.
t Three analyses of the same sample.
t Aminoethylated sample.
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It is significant that both Y136Gly and 7y136Ala are present in hemoglobin F,(= Fo)
of samples 1-13, 16, 20, and 22 (Table 2). None of the individuals is "homozy-
gous" at position 136. If a pair of allelic genes at a single locus was involved in
producing Y136GlY and 7136Ala chains, homozygotes for both 713601y and 7136Ala
should have been detected even in this relatively small number. For example,
Walsh et al.'6 observed an almost exact Mendelian distribution of heterozygotes
and homozygotes in a similarly sized population. As would be expected,
7136Ala chains are present in the Fo's of W. B. and C. W. whose F 's are derived
solely from 7136G1y chains. However, it is important to realize that 0 136Ama chains
are also present in the Fo's of D. P. and J. B. (samples 16 and 22 which were not
contaminated with hemoglobins F.), where Fz is derived solely from 7136Ama
chains. The analysis (Table 2) and PTH-degradation of Fo from D. P. show
this. Ambiguity of translation cannot be invoked to explain the presence of
7136Ala chains in samples 16 and 22 because the abnormal hemoglobins give no
evidence of ambiguity.
The data, therefore, cannot be explained by ambiguity of translation or by
heterozygosity at a single locus. The situation may be analogous to that of the
goat a chains.2' More than one pair of allelic genes that code for the y chain is
assumed. In the simplest case, this may be represented by diagram A
136GlY 136Ala on homologous chromosomes; the relative arrangement#yGY 3 is, of course, arbitrary and the genes may or may not be
136Ala closely linked or adjacent. Although the normal individ-
..36GY 7 ual would be homozygous at each locus, both products
would appear, the abnormal fetal hemoglobins would re-A sult from a mutation of one of the alleles of the ap-
propriate gene, and hemoglobin Fo from an individual with an F, would have the
two types of Y chains.
The quantitative aspects of the data, on the other hand, cannot easily be ex-
plained by this simple model. If equal gene products resulted, the ratio of
y136GIy to y136AIa chains would be 1 and the analysis of the mixed 7CB-3 peptide
should have 0.5 residue of glycine and 2.5 residues of alanine. Actually, the
average of samples 1-12 is 0.77 residue of glycine and 2.27 residues of alanine.
It is pertinent to consider the meaning of the average because of the range of
values in samples 1-12 and because sample 18, which by PTH-degradation has
no glycine in residue 3 of yCB-3 (Fig. 2), shows 0.16 residue by analysis (Table
2). The anticipated sum of glycine and alanine is 3.00 residues. Of the analyses
in Table 2, all but five fall between 3.00 and 3.10 residues or within a range of 3
per cent, which is the expected precision of the analyses. The fact that the sum
always equals 3.00 or more and averages 3.06 suggests that a small and somewhat
variable amount of extraneous glycine may be present. This problem has been
further investigated by sectioning the peak from Dowex-1 chromatography into
parts and analyzing each: sections at front and tail of the peak each constituted
about 5 per cent of total material and two center sections about 45 per cent.
The presence of extraneous glycine was evident in both the front and tail sections
because the sum of glycine and alanine was sometimes as much as 3.5; in the
center sections values of 3.0-3.1 were observed. If all the data are used to cal-
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culate the analytical results for the unsectioned peak, the results differ by only a
few per cent from those of the center sections. When the sum of glycine and
alanine is 3.0-3.1 residues, a difference of more than 0.1 residue of glycine be-
tween two samples may be real. Consequently, all samples depart from the
value of 0.5 residue of glycine in residue 136 that would be expected from the
simple model.
If the variation around the average is disregarded for the moment, it is evident
that the observed average of 0.77 residue of glycine in residue 136 could result
from diagram B, if each cistron yielded equal product.
136GIy 136Gly 136Gly 7136AIa This concept is especially attractive
Iy 'Y a when we examine the observed percent-
,136Gly ,y136Gly 136Gly 136Ala ages of hemoglobins F,. Table 1 listsGI i 7 |1St the amount of abnormal hemoglobins
in per cent of the fetal hemoglobin com-
B ponents (Fo + F, + F.). These values
are near 12.5 per cent or '/8 as would be expected if a mutation of any of the eight
alleles produced a hemoglobin F.. This fraction remains essentially constant
as the fetal hemoglobin decreases with the age of the child. Other fetal hemo-
globins abnormal in the y chain are present in similar percentage: FRoma,
17% (ref. 22); FTexas, 12% (ref. 4); FHouston, 15% (ref. 23); and FWaen, 14%
(ref. 5).
On the basis of this model, the ratio of _Y136G1Y to 7136A1a chains in the hemoglo-
bin Fo of an individual with a hemoglobin Fi would depend upon whether F de-
rived from a Y136G1y or a _Y136A1a allele. Thus, when FC has alanine at residue
136, FO and Fx would be derived from the eight alleles as follows:
-__ __ __ __ _-
.. e e e e. . ..........F
7136GIy 7136GIy 7136G1y I 136A1a :
......
136G0y 136G1y 136Gly 136AIa
7l6lyto736Y]Fo" ----__J
The ratio of y136Gly to Y136Ala chains in the Fo should be 6:1, and the calculated
residues of glycine in residue 136 of Fo should be 0.86: the data from F0 of D.
P. (sample 16) and J. B. (sample 22) are in excellent agreement. In like man-
ner, when Fx derives from a 7136G1Y allele, the ratio should be 5:2, which corre-
sponds to 0.71 residue of glycine at residue 136 of Fo. W. B. (sample 19) and C. W.
(sample 20) are cases in point. The value of 0.83 residue of glycine in Fo from
C. W. does not agree well if the accuracy of the determination is as good as was
suggested above; Fo of W. B. was not available. There is, in fact, no appreciable
difference in the glycine content at residue 136 for the Fo's of D. P., C. W., and
J. B., despite the basic difference in the Fx's. Because the number of examples
is small, the conflicting results do not entirely rule out the possibility of four
structural genes for the y chain, but the idea is less tenable.
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On the other hand, an explanation of these results is not more easily elicited
from current concepts of the control of protein synthesis especially as they relate
to the hemoglobins. It is well known that the heterozygote for hemoglobin A
and an abnormal hemoglobin does not usually produce the two in equal amount.
It has been suggested that this inequality of production by allelic genes results
either because the structure of the polypeptide chain itself determines the rate of
production24' 25 or because regulator genes determine the rate of synthesis ac-
cording to the model of Jacob and 'Monod for bacterial systems.26
The structure-rate hypothesis is easily applicable to the first model of two
structural genes for the e chain. One simply assumes that the 7136G1y gene syn-
thesizes at three times the rate of the oy136A1a gene so that the product as isolated
has 0.75 residue of glycine in residue 136. In the same way, when an individual
has an F, that derives from a Y136A1a allele, the structure-rate hypothesis can ex-
plain the percentage of F, and the ratio of Y136G1y to _136Ala chains in the Fo.
When the Fx derives from a 7136G1y allele, the hypothesis is unsatisfactory:
one would expect the percentage of Fx to be 37.5 per cent, and Fo should have 0.6
residue of glycine in residue 136.
Many authors have pointed out that evidence does not exist for regulator
genes in mammaliais systems, and have also noted that a sufficiently complex
arrangement of inducers, repressors, and controlling elements can be made to
play any kind of trick.27 Although it may be possible to explain the present re-
sults in these terms, this exercise has not been carried out.
That some rate-controlling factor, whatever it may be, is responsible for the
observed relationships in the product of the oy chain genes is suggested not only
by the range of values from subjects 1-12, but also by data from the goat a
chains.28 In this instance, a mutant of one of the two probable structural genes
has been observed in heterozygous and homozygous state. The data indicate a
difference in the rates of chain production by the two related structural genes and
by the mutant form of one of them. Unavailability of some of the data in the
case of the human y chain prevents strict comparison. It is also relevant that
Winslow and Ingram1129 have observed distinctly different rates of synthesis for
the human 0 and 6 chains, the genes for which are believed to be closely linked.
Although it is not possible to interpret all aspects of the present data, there is
persuasive evidence that more than one structural gene codes for the synthesis
of the human y chain. It is hoped that pertinent information will result from
the examination of fetal hemoglobin that persists into adult life as is observed,
for instance, in thalassemia, sickle cell anemia, and the hereditary persistence of
fetal hemoglobin. We are currently examining hemoglobin Fo from individuals
with such conditions. Data about J. L., who has hereditary persistence of fetal
hemoglobin combined with hemoglobin C, are shown in Figure 2. The presence
of approximately equal amounts of glycine and alanine observed in residue 3 of
J. L.'s -yCB-3 peptide is substantiated by amino acid analysis. On the other
hand, the fetal hemoglobins from a mother and two daughters in an unrelated
family have only glycine in residue 136. The data will be discussed in detail
elsewhere.
Sunmary.-Human fetal hemoglobin in the normal infant at birth is composed
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of at least two components that are not separable by chromatography or electro-
phoresis. At a minimum, they differ in the exchange of glycine and alanine in
position 136 of the -y chain. On the basis of evidence from abnormal human
fetal hemoglobins, it is concluded that these types of y chains are the products
of more than one structural gene and are not the results of ambiguity of transla-
tion of the genetic material. The quantitative relationships that have been ob-
served are not easily explained on the basis of current concepts of the control
of protein synthesis.
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